Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -11.31% | 13.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.31% | 13.17% | |||
| Cost of Revenue | 13.30% | -18.35% | |||
| Gross Profit | -24.19% | 41.81% | |||
| SG&A Expenses | -10.45% | 12.36% | |||
| Depreciation & Amortization | 0.05% | -0.37% | |||
| Other Operating Expenses | 111.53% | 80.10% | |||
| Total Operating Expenses | 12.37% | 5.61% | |||
| Operating Income | -115.86% | 18.26% | |||
| Income Before Tax | -73.85% | -4.92% | |||
| Income Tax Expenses | -138.89% | -2.70% | |||
| Earnings from Continuing Operations | -73.62% | -4.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 139.80% | 2.97% | |||
| Net Income | -73.01% | -4.88% | |||
| EBIT | -115.86% | 18.26% | |||
| EBITDA | -163.54% | 23.89% | |||
| EPS Basic | -71.60% | -2.74% | |||
| Normalized Basic EPS | -66.82% | -2.93% | |||
| EPS Diluted | -77.51% | -2.74% | |||
| Normalized Diluted EPS | -66.82% | -2.93% | |||
| Average Basic Shares Outstanding | 0.76% | 1.94% | |||
| Average Diluted Shares Outstanding | 0.76% | 1.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||